liver disease – Allocare

June 28, 2023June 28, 2023

VCU researchers want to develop better tools to help diagnose millions of patients with liver disease

The study is funded by a $2.87 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.

By A.J. Hostetler

Researchers at the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University hope a new five-year study will help them develop better diagnostic tools for patients with an aggressive liver disease that is a leading cause for liver transplantation.

In patients suffering from metabolic dysfunction-associated steatotic liver disease (MASH, formerly called NASH), a build-up of fat in the liver damages cells and causes inflammation.
Read the full article in the VCUHealth News Center.

July 18, 2022August 16, 2022

A liver disease has long been untreatable. Now a SLU researcher has a solution.

ST. LOUIS — A rare genetic liver disease that afflicts 100,000 Americans has evaded treatment by scientists and doctors for decades.

Now, after 29 years of research, a St. Louis University scientist and his team are on the cusp of a solution. Read the full article in the St. Louis-Dispatch.

May 3, 2022August 16, 2022

What’s the Mysterious Liver Disease Hurting Children?

An outbreak of acute hepatitis — an inflammation of the liver — in children has killed at least four and required liver transplants in more than a dozen others across the globe, according to the World Health Organization. While the cause is undetermined, investigators are studying a family of pathogens, called adenoviruses, that cause a range of illnesses including the common cold. Read the full story in The Washington Post here.